Michael Ball is a leader with over 30 years of experience scaling global companies to acquisition and IPO. As Founder and CEO of MarkeTech Consulting, he advises on precision health, life sciences, and diagnostics. Previously, he was CEO of Canexia Health, expanding its global client base and advancing oncology diagnostics. As Global VP at Illumina, he tripled informatics sales and led post-acquisition integration. His career also includes executive roles at GenoLogics and Creo, driving growth, IPOs, and acquisitions.